Newsbenzinga
EXCLUSIVE: FibroBiologics Files Patent Application For Cell-Based Alternative to GLP-1 Injections
· Published
Article summary
FibroBiologics files a U.S. patent application for engineered cell technology designed to supply continuous GLP-1 therapy internally.
An excerpt from the original article.
Comments —
Loading comments…